CRISPR THERAPEUTICS AG
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $915.2M | $373.5M | $377.7M |
| FY2022 | $1.2M | $-673.2M | $-650.2M |
| FY2023 | $371.2M | $-222.5M | $-153.6M |
| FY2024 | $37.3M | $-466.6M | $-366.3M |
| FY2025 | $3.5M | $-664.6M | $-581.6M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $915.2M | $373.5M | $377.7M |
| FY2022 | $1.2M | $-673.2M | $-650.2M |
| FY2023 | $371.2M | $-222.5M | $-153.6M |
| FY2024 | $37.3M | $-466.6M | $-366.3M |
| FY2025 | $3.5M | $-664.6M | $-581.6M |